Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Asset Utilization Ratio (2016 - 2026)

Agios Pharmaceuticals (AGIO) has disclosed Asset Utilization Ratio for 14 consecutive years, with 0.05 as the latest value for Q1 2026.

  • For Q1 2026, Asset Utilization Ratio rose 131.25% year-over-year to 0.05; the TTM value through Mar 2026 reached 0.05, up 131.25%, while the annual FY2025 figure was 0.04, 30.02% up from the prior year.
  • Asset Utilization Ratio hit 0.05 in Q1 2026 for Agios Pharmaceuticals, up from 0.04 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.05 in Q1 2026 and bottomed at 0.0 in Q1 2022.
  • Average Asset Utilization Ratio over 5 years is 0.02, with a median of 0.02 recorded in 2025.
  • Year-over-year, Asset Utilization Ratio crashed 99.14% in 2022 and then skyrocketed 2552.53% in 2023.
  • Agios Pharmaceuticals' Asset Utilization Ratio stood at 0.01 in 2022, then surged by 134.35% to 0.03 in 2023, then decreased by 23.42% to 0.02 in 2024, then skyrocketed by 90.63% to 0.04 in 2025, then skyrocketed by 32.13% to 0.05 in 2026.
  • According to Business Quant data, Asset Utilization Ratio over the past three periods came in at 0.05, 0.04, and 0.03 for Q1 2026, Q4 2025, and Q3 2025 respectively.